Emergent BioSolutions (EBS) Proxy filing summary

Executive summary

• Annual meeting of stockholders scheduled for April 29, 2026, at 9 a.m. Eastern Time.

• Only shareholders of record as of March 6, 2026, are eligible to vote at the meeting.

• Shareholders are encouraged to review the proxy statement and related SEC filings for important information.

Voting matters and shareholder proposals

• Eligible shareholders can vote even if not attending the virtual meeting by submitting a proxy vote.

• Voting instructions will be sent via E*TRADE email, and support is available for account access issues.

Shareholder rights and capital structure

• Only vested shareholders as of the record date are entitled to participate in voting.